CSBR [NASD]
Champions Oncology, Inc.
Index- P/E227.00 EPS (ttm)0.03 Insider Own29.29% Shs Outstand13.50M Perf Week-8.96%
Market Cap90.85M Forward P/E32.43 EPS next Y0.21 Insider Trans0.00% Shs Float10.24M Perf Month-14.45%
Income0.40M PEG15.13 EPS next Q0.03 Inst Own72.50% Short Float0.57% Perf Quarter-14.66%
Sales46.80M P/S1.94 EPS this Y114.90% Inst Trans0.04% Short Ratio9.40 Perf Half Y-29.94%
Book/sh0.68 P/B10.01 EPS next Y162.50% ROA1.50% Target Price14.67 Perf Year-32.10%
Cash/sh0.65 P/C10.44 EPS next 5Y15.00% ROE5.40% 52W Range7.06 - 11.25 Perf YTD-18.54%
Dividend- P/FCF90.85 EPS past 5Y15.10% ROI3.90% 52W High-39.47% Beta1.03
Dividend %- Quick Ratio1.20 Sales past 5Y29.70% Gross Margin50.80% 52W Low-3.54% ATR0.23
Employees194 Current Ratio1.20 Sales Q/Q22.20% Oper. Margin1.30% RSI (14)32.38 Volatility3.21% 2.74%
OptionableYes Debt/Eq0.00 EPS Q/Q-17.30% Profit Margin0.90% Rel Volume0.18 Prev Close7.25
ShortableYes LT Debt/Eq0.00 Earnings- Payout0.00% Avg Volume6.18K Price6.81
Recom2.00 SMA20-9.17% SMA50-13.67% SMA200-22.72% Volume1,123 Change-6.07%
Nov-18-19Initiated The Benchmark Company Speculative Buy
May-03-22 08:30AM  
May-02-22 01:16PM  
Mar-15-22 04:45PM  
Mar-11-22 08:30AM  
Mar-07-22 01:10PM  
Feb-15-22 08:30AM  
Jan-20-22 08:30AM  
Jan-04-22 08:30AM  
05:07AM  
Dec-13-21 04:20PM  
Dec-06-21 09:20AM  
Nov-05-21 08:24AM  
Oct-20-21 10:25AM  
Sep-13-21 04:00PM  
Sep-06-21 03:00PM  
07:09AM  
Sep-02-21 04:30PM  
Jul-26-21 08:30AM  
Jul-22-21 08:00AM  
Jul-14-21 08:30AM  
Jul-08-21 03:06AM  
Jun-15-21 09:00AM  
Apr-29-21 03:31AM  
Apr-16-21 12:00PM  
Mar-16-21 10:52AM  
Mar-15-21 02:13AM  
Mar-11-21 04:00PM  
02:30PM  
Mar-05-21 08:30AM  
Mar-04-21 12:30PM  
Feb-22-21 09:00AM  
Jan-29-21 12:24AM  
Jan-19-21 09:00AM  
Jan-05-21 08:30AM  
Dec-15-20 12:22AM  
Dec-14-20 04:00PM  
Dec-07-20 04:00PM  
Nov-16-20 04:40PM  
Nov-11-20 09:00AM  
Oct-31-20 10:08AM  
Sep-16-20 07:27AM  
Sep-14-20 04:00PM  
Sep-08-20 04:30PM  
Jul-30-20 07:21AM  
Jul-27-20 04:01PM  
Jul-22-20 08:00AM  
Jul-15-20 03:55PM  
Jun-17-20 09:37AM  
May-27-20 07:05AM  
Apr-28-20 09:50AM  
Apr-27-20 07:20AM  
Mar-28-20 09:23AM  
Mar-16-20 09:35AM  
Mar-12-20 04:17PM  
Mar-10-20 08:30AM  
Feb-26-20 09:32AM  
Feb-18-20 05:44AM  
Feb-05-20 09:23AM  
Jan-29-20 09:00AM  
Jan-17-20 09:34AM  
Jan-13-20 06:07AM  
Dec-24-19 09:37AM  
Dec-16-19 04:00PM  
Dec-09-19 08:30AM  
Dec-08-19 08:59AM  
Dec-04-19 08:36AM  
Nov-14-19 08:53AM  
Nov-13-19 05:00PM  
Nov-12-19 07:27AM  
Oct-24-19 09:00AM  
Oct-18-19 07:41AM  
Oct-03-19 08:49AM  
Sep-25-19 12:43PM  
Sep-16-19 04:00PM  
02:30PM  
Sep-13-19 08:39AM  
Sep-09-19 08:30AM  
Sep-02-19 01:30PM  
Aug-26-19 08:37AM  
Aug-05-19 08:42AM  
Jul-29-19 06:48PM  
Jul-26-19 06:58AM  
Jul-15-19 04:35PM  
Jul-12-19 10:00AM  
Jul-02-19 09:35AM  
May-31-19 09:37AM  
May-30-19 08:30AM  
May-01-19 08:07AM  
Apr-17-19 09:49AM  
Apr-16-19 10:51AM  
Apr-01-19 08:54AM  
Mar-27-19 10:03AM  
Mar-25-19 10:42AM  
Mar-18-19 04:00PM  
Mar-06-19 08:30AM  
Mar-04-19 11:40PM  
Jan-10-19 08:43AM  
Dec-17-18 03:30PM  
03:00PM  
Dec-10-18 04:30PM  
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SIDRANSKY DAVIDDirectorOct 15Option Exercise1.5916,66726,501764,901Oct 19 03:39 PM
TOBIN SCOTT RDirectorOct 12Option Exercise1.5910,00015,90020,000Oct 13 10:26 AM